HAP Trading, LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2022$27,000
+50.0%
13,900
-26.8%
0.00%0.0%
Q1 2022$18,000
+63.6%
19,000
-8.7%
0.00%
Q4 2021$11,000
+57.1%
20,800
+50.7%
0.00%
Q3 2021$7,00013,8000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders